Holds one active US DMF and one valid CEP for enoxaparin, filing since 2005. Its 2018 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for enoxaparin, filing since 2020. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 5 markets.
Holds one active US DMF for enoxaparin, filing since 2012. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for enoxaparin, filing since 2013. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF for enoxaparin, filing since 2017. Its 2025 FDA inspection closed as NAI.
Holds one active US DMF for enoxaparin, filing since 2017. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for enoxaparin, filing since 2011. Its GMP is recognised in 1 market.
Holds one active US DMF for enoxaparin, filing since 2014.
This page filters the worldwide Enoxaparin manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for enoxaparin and what filings they hold.
Chat with Fred, your AI analyst